Latest Regulatory Changes News

Mayfield Childcare has pulled its FY26 earnings guidance amid rising costs and regulatory shifts, while cautiously advancing its Mayfield 360 allied health initiative.

Qoria Limited marked a turning point in FY25, delivering 25% growth in Annual Recurring Revenue and a 684% jump in underlying EBITDA, setting sights on 20% EBITDA margin in FY26 amid global digital safety expansion.

Stakk Ltd anticipates its first operating profit in FY2026, driven by a surge in recurring revenue and major contract wins, with FY2027 revenue projected at $21.8 million based on existing agreements.

Booster Innovation Fund reported a $1.593 million profit for the year ended March 2026, supported by increased net assets. However, valuation risks persist due to early-stage investments and recent capital raises at lower prices.

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

Centuria Capital Group launches a $300 million fully underwritten equity raise to accelerate its AI Factory pipeline via ResetData and expand its real estate and credit funds platform.

Bougainville Copper Limited has been officially notified that its Exploration Licence No. 01 is suspended following the Bougainville Executive Council’s approval of a 25-year Large-Scale Mining Lease granted to Bougainville Minerals Limited over the same land.

Sweden's Parliament has amended legislation to remove uranium mining from nuclear facility regulations, simplifying permits and strengthening Aura Energy's prospects for its Häggån uranium deposit.

EDU Holdings lifted total student enrolments by 32% in Trimester 2 2026, driven by strong growth at its higher education arm Ikon Institute, offsetting softness in its vocational training division.

Eureka Group Holdings (ASX: EGH) expects FY26 underlying EBITDA to meet or exceed $21.1 million, driven by seniors’ occupancy above 97% and rent growth exceeding 6%. Capital recycling and a robust acquisition pipeline support growth.

Vita Life Sciences projects a slight increase in H1 2026 sales and stable pre-tax profits, supported by strong markets in Australia and Malaysia/Singapore but offset by regulatory headwinds in China.

Barramundi Limited’s May update reveals a 2.3% adjusted NAV decline, weighed down by CSL’s earnings downgrade and Brambles’ operational setbacks, despite positive contributions from Xero and Credit Corp.